{
    "nctId": "NCT02606110",
    "briefTitle": "Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer",
    "officialTitle": "N/A",
    "overallStatus": "WITHDRAWN",
    "conditions": "Peripheral Neuropathy",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Changes in touch and sensory by way of change in the Semmes-Weinstein Monofilament Testing",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with breast cancer referred to Physical Therapy for CIPN\n* Physical Therapy Examination indicates use of Rebuilder for CIPN\n* At least 18 years of age\n* Signed informed consent for study population\n* Willingness to complete study according to protocol\n\nExclusion Criteria:\n\n* Patients who do not have CIPN\n* Patients \\<18 years of age\n* Inability to or unwilling to sign informed consent\n* Unable to read and understand the English language\n* Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism\n* More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}